Werewolf Therapeutics, Inc. (HOWL) — DEF 14A Filings
All DEF 14A filings from Werewolf Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Werewolf Therapeutics Files Proxy Statement
— Apr 28, 2025 Risk: low
Werewolf Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 28, 2025, for its annual meeting on June 12, 2025. The filing outlines the c -
Werewolf Therapeutics Announces 2024 Annual Meeting of Stockholders
— Apr 12, 2024 Risk: low
Werewolf Therapeutics, Inc. (HOWL) filed a Proxy Statement (DEF 14A) with the SEC on April 12, 2024. Annual meeting to be held virtually on May 24, 2024, at 9:0
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX